Skip to content
Home/Companies/Biotech/Stalicla
Stalicla

Stalicla

Biotech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Stalicla?

Stalicla is a French Biotech company, currently owned by Yaday since 2021 and LIFTT.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
LIFTT
Most recent investor
LIFTT
LIFTT · 2019 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Websitestalicla.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Yaday and LIFTT since 2021.
Co-invest · 2 holders · 2021 · present
Yaday
YadayActive
2021 · present(5yr) · AA Sons Legacy · 2016 · VC
LIFTT
LIFTTActive
2021 · present(5yr) · LIFTT · 2019 · VC

More from LIFTT

Other portfolio companies in the same fund.

Rainbow Crops
Active
AgTechBelgium· 2026
Vitrealab
Active
Deep TechAustria· 2026
Agate Sensors
Active
Deep TechFinland· 2025
Qsensato
Active
Deep TechItaly· 2025
RAAAM Memory Technologies
RAAAM Memory Technologies
Active
Deep TechIsrael· 2025
Composite Research
Composite Research
Active
IndustrialsItaly· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Stalicla?

Stalicla is currently owned by Yaday and LIFTT, through LIFTT, since 2021.

When did Yaday and 1 other acquire Stalicla?

Yaday and 1 other acquired Stalicla in 2021.

Who has owned Stalicla over time?

Stalicla has been through 2 private-equity ownership periods: Yaday · via AA Sons Legacy · since 2021; LIFTT · via LIFTT · since 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue